MXPA04011768A - Mejoras relativas a funciones inmunes. - Google Patents

Mejoras relativas a funciones inmunes.

Info

Publication number
MXPA04011768A
MXPA04011768A MXPA04011768A MXPA04011768A MXPA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A MX PA04011768 A MXPA04011768 A MX PA04011768A
Authority
MX
Mexico
Prior art keywords
unit dose
liquid form
phosphotidyl
resveratrol
psk
Prior art date
Application number
MXPA04011768A
Other languages
English (en)
Spanish (es)
Inventor
Donald Farley Michael
Original Assignee
Donald Farley Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donald Farley Michael filed Critical Donald Farley Michael
Publication of MXPA04011768A publication Critical patent/MXPA04011768A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA04011768A 2003-01-09 2003-01-09 Mejoras relativas a funciones inmunes. MXPA04011768A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/000709 WO2004062683A1 (en) 2003-01-09 2003-01-09 Improvements in or relating to immune functions

Publications (1)

Publication Number Publication Date
MXPA04011768A true MXPA04011768A (es) 2005-03-31

Family

ID=34885486

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011768A MXPA04011768A (es) 2003-01-09 2003-01-09 Mejoras relativas a funciones inmunes.

Country Status (7)

Country Link
EP (1) EP1581238B1 (enExample)
JP (1) JP2006501308A (enExample)
CN (1) CN100579535C (enExample)
AT (1) ATE395925T1 (enExample)
DE (1) DE60321227D1 (enExample)
MX (1) MXPA04011768A (enExample)
WO (1) WO2004062683A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
ES2428665B1 (es) * 2012-05-04 2014-10-01 Universidad De Valladolid Composición para su uso en el tratamiento y/o prevención de la inflamación, el estrés oxidativo y la neovascularización ocular
CN106974904B (zh) * 2017-03-14 2020-07-28 南方医科大学 杨梅素及其衍生物的新用途和一种抗hiv感染的杀微生物剂
CN110772578A (zh) * 2019-11-11 2020-02-11 李胜 一种用于癌症防治的人体免疫力增强剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175985A1 (en) * 1995-05-10 1996-11-11 Yoichi Kiyosuke Pharmaceutical composition containing substance inhibiting hsp47 production
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
ATE245364T1 (de) * 1996-09-20 2003-08-15 Howard Foundation Flavanol enthaltende nahrungsergänzungszusammensetzungen
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance

Also Published As

Publication number Publication date
EP1581238A1 (en) 2005-10-05
JP2006501308A (ja) 2006-01-12
ATE395925T1 (de) 2008-06-15
CN100579535C (zh) 2010-01-13
EP1581238B1 (en) 2008-05-21
DE60321227D1 (de) 2008-07-03
CN1638786A (zh) 2005-07-13
WO2004062683A1 (en) 2004-07-29
HK1078471A1 (en) 2006-03-17

Similar Documents

Publication Publication Date Title
US6544564B1 (en) Cytotoxic pharmaceutical composition
Park et al. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines
Yuan et al. In vitro and in vivo inhibitory effects of a Pleurotus eryngii protein on colon cancer cells
WO2017141104A8 (en) Method for inducing a sustained immune response
US6767563B2 (en) Immune functions
WO2006087759A2 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
RU2252029C1 (ru) Оздоровительно-профилактическая композиция, включающая комбинации соевого фосфолипидного комплекса и экстрактов лекарственных растений, и биологически активная добавка на основе этой композиции
Ghate et al. Polyphenols, spices and vegetarian diet for immunity and anti-inflammatory drug design
Tiwari et al. Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin
MXPA04011768A (es) Mejoras relativas a funciones inmunes.
Grover et al. Curcumin: A medicinal plant and its effects in medicine and dentistry
CO6241128A2 (es) Compuestos extraidos de residuos de molienda de aceite de palma para el tratamiento del cancer composiciones de los mismos y metodos acompañantes
Lin et al. The ethanolic extract of Taiwanofungus camphoratus (Antrodia camphorata) induces cell cycle arrest and enhances cytotoxicity of cisplatin and doxorubicin on human hepatocellular carcinoma cells
WO2016057840A1 (en) Cannabidiol compositions including mixtures and uses thereof
Gupta Synergistic anti-cancer effects of natural products and their mode of action
Koriem Cortex Uncariae: A review on pharmacology, toxicology, precautions, and dosage
Alavi Dana et al. Anti-cancer Potential of Hypericum spp. with Focus on Hypericum Perforatum: A Review of the Literature
Sekhar et al. A review on anticancer potential of natural drugs: hispolon and limonene
Wimardhani et al. Oral mucosal ulceration caused by the topical application of a concentrated propolis extract
HK1078471B (en) Improvements in or relating to immune functions
MX2022007304A (es) Uso de lemborexant para tratamiento del insomnio.
Bawa et al. Clinical Uses of Piperine: A Review
Ibrahim et al. Effect of Salvia triloba L. f. extracts on neoplastic cell lines
Shen et al. Research progress on the anti-cancer mechanisms of edible salty-flavored Chinese materia medica
JP2014224083A (ja) 性機能増強組成物

Legal Events

Date Code Title Description
FG Grant or registration